Patients with diabetic are more sensitive to local anesthetic(LA) neurotoxicity. Our team found that the reason for neurons in hyperglycemia more susceptible to LA is excess production of reactive oxygen species (ROS) . Previous studies have shown that PPARγ as a target of transcription factor KLF9 can regulate intracellular ROS levels and protect cells. Preliminary data showed Preliminary data from our team showed bupivacaine reverse the effect of KLF9 in neurons cultured in HG, from protect to damage effect with histone deacetylation, lower PPARγ expression and ROS overproduction. Inhibitor of Histone deacetylases(HDAC) could stop inhibition effect of KLF9 on PPARγ to improve, reduce ROS, protect cells. We speculate that under exposure to bupivacaine more KLF9 binding to HDAC which result to epigenetically inhibition of KLF9 transcription effect, result in lower PPARγ expression, ROS burst, and neuronal damage. If we could inhibitor the binding between KLF9 and HDAC, KLF9 would only show protective effect. In this study plasmid transfection, gene editing and other molecular biology techniques will be used, and Induced pluripotent stem cells(ipsc)-induced human neural cells and specific transgenic animals will be recruited as the research objects. The aim of the study is to investigate the mechanism underlying the patients with DM is more sensitive to neurological toxicity of LA and to provide a potential target for treatment of the nerve damage caused by bupivacaine.
糖尿病患者对局麻药(LA)神经毒性更敏感,本团队发现该临床现象与活性氧(ROS)产生过多有关。转录因子KLF9可促进过氧化物酶体增殖物激活受体γ(PPARγ)转录,后者减少ROS而保护高糖环境中的(HG)神经细胞。预实验发现:暴露于布比卡因(Bup)后,HG神经细胞的组蛋白去乙酰化增加,KLF9的保护作用转为损伤,伴PPARγ表达下降,ROS产生增多,损伤加剧。组蛋白去乙酰化酶(HDAC)的拮抗剂可逆转KLF9的损伤作用。因此提出假设:暴露于Bup后,HG神经细胞KLF9与HDAC紧密结合,组蛋白去乙酰化增加,KLF9从促进PPARγ转录转为抑制,增加ROS产生,损伤加剧;若阻断KLF9与HDAC结合,则从表观遗传学层面增强其保护作用。本研究拟采用质粒转染,基因编辑等手段,诱导人多能干细胞(iPSC)获得的的神经细胞及特异性转基因动物为研究对象,予以证实。有利于防治LA加重糖尿病神经损伤。
糖尿病患者对局麻药(LA)神经毒性更敏感,本团队发现该临床现象与活性氧(ROS)产生过多有关。转录因子KLF9可促进过氧化物酶体增殖物激活受体γ(PPARγ)转录,后者减少ROS而保护高糖环境中的(HG)神经细胞。本团队发现HG中神经细胞中KLF9表达增加,当敲除KLF9后,损伤加重,因此HG中KLF9具有保护作用;当暴露于布比卡因(Bup)后,HG神经细胞的组蛋白去乙酰化增加,KLF9的保护作用转为损伤,伴PPARγ表达下降,ROS产生增多,损伤加剧。KLF9虽然可结合于PPARγ,但不同组间二者结合能力不同,不是直接影响PPARγ的转录。但我们组蛋白去乙酰化酶(HDAC)的拮抗剂可逆转KLF9的损伤作用。HG神经细胞暴露于Bup后,KLF9与HDAC紧密结合,组蛋白去乙酰化增加,KLF9从促进PPARγ转录转为抑制,增加ROS产生,损伤加剧;若阻断KLF9与HDAC结合,则从表观遗传学层面增强其保护作用。除了研究KLF9/HDAC/PPARγ外,我们还发现了,KLF9对ROS的影响,是通过调节抗氧化酶PRDX6的表达实现的。HG+Bup是的KLF9表达增加,PRDX6水平下降,细胞内抗氧化能力下降,导致细胞损伤增加。.本研究探究了高糖环境内神经细胞对局部麻醉药神经毒性敏感性增加可能的分子机制,为糖尿病周围神经病患者围术期的神经保护提供了可能的靶点
{{i.achievement_title}}
数据更新时间:2023-05-31
DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素
转录组与代谢联合解析红花槭叶片中青素苷变化机制
Novel alternative splicing of GABA receptor RDL exon 9 fromLaodelphax striatellusmodulates agonist potency
掘进工作面局部通风风筒悬挂位置的数值模拟
当归红芪超滤物对阿霉素致心力衰竭大鼠炎症因子及PI3K、Akt蛋白的影响
TLR4在高糖加重缺血性肾小管损伤中的作用及机制
T型钙通道在局麻药神经细胞毒性损伤中的作用研究
MCU/ROS在布比卡因加重糖尿病小鼠神经损伤中的作用
全麻药经TRPA1-TRPV1途径加重局麻药所致糖尿病小鼠神经毒性损伤的机制研究